The path to true transparency

  • August 7, 2019
Sameer Awsare, MD, FACP, focuses on government rules and state laws attempting to hold pharmaceutical companies accountable to escalating prescription drug prices, and asks what's true transparency?
Read More

The price is wrong

  • February 19, 2019
Sameer Awsare, MD, associate executive director at The Permanente Medical Group, addresses the need to curb prices on biologics to protect patients.
Read More